FDA Investigator James K Ireland

James K Ireland has inspections in 3 countries as of 13 Nov 2023. James K Ireland has collaborated with a combinined 3051 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
45
Last Inspection Date:
13 Nov 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, Italy, United Kingdom of Great Britain and Northern Ireland
Co-Investigator(s):
Aaron L Dunbar, Alecia L Marson, Amy L Mcintyre, Ana M Placencia, Anthony J Ladner, April L Young, Arthur G Hurst, Azza Talaat, Baask, Benedict, Benjamin W Anderson, Bradley A Servais, Brenda W Uratani, PhD, Brentley S Collins, Brian L Szcyubialka, Bryan L Mcguckin, Carolyn A Warren, Catherine V Quinlan, Charles I Ann, Charles L Zhou, Charles R Cote, RIC, Christian D Lynch (CDL), Christina A Miller, Christine M Erickson, Como, Constance Lrichard Math, Corey K Reno, Courtney R Ingalsbe, Courtney R Tiegs, Dacia E Quick, Dale A Nyberg, Danial S Hutchison, Daniel J Brown, Darren S Morgan, David J Gasparovich, David J Ward, David P Rice, Dawn C Olenjack, Demetria L Lueneburg, Denise L Burosh, Douglas J Snyder, Duc Minh H Nguyen, Edward M James, Eliezar Ramos, Emilie E Kahn, Emily E Markgraf, Emily J Orban, Fannie M Harrell, Frank S Sedzielarz, French, Gene D Arcy, Geneve M Maxwell, Geneve M Parks, Geneve Maxwell, Grant M Ruis, Greg A Abel, Gregory A Berg, Gregory W Smith, Gwyn G Dickinson, Heather Akleimola Hulbert, Helen B Ricalde, Howard A Burmester, Ivan E Reyes, Jacob G Lutz, Jacob W Reynolds, Jacqueline Mdiaz Albertini, James A Beaulieu, Janet L Bowen, Janis R Armedoriz, Jasjeet K Sekhon, Jeffrey A Sommers, Jeffrey D Meng, Jeffry A Bernhardt, Jennifer Al Vollon, Jennifer Alongie Vollom, Jennifer Guttuso, Jennifer S Ness, Jesse P Romenesko, Jessica L Barr, Joel D Hustedt, John E Emmert, John P Hermann, Jonathan G Gayechuway, Jonathan L Blonk, Jose Alopez Rubet, Joseph D Gong, Justin A Boyd, Justin J Jafferis, Karla J Youngberg, Katherine A Clarke Girolamo, Kathy Ac Girolamo, Kellie L Westerbuhr, Kenneth A Libertoski, Kibily D Dembele, Kristy E Zuroski, Kyle J Mccracken, Lauren E Sanger, Leslie A Paul, Linda V Weyer, Lisa M Lopez, Lori B Wikstrom, Maere A Fadden, Maria E Treadwell, Marie A Fadden, Martha Sullivan Myrick, Matthew J Gretkierewicz, Melissa I Michurski, Michele L Forster, PhD, Michele Perry Williams, Mihaly S Ligmond, Minerva Rogers, Mohammed H Adam, Myra K Casey, Nadine J Nanko, Nancy A Saxenian Emmons, Paranthaman Senthamaraikannan, Patricia A Holmstrom, Patrick J Campbell, Patsy I Domingo, Patsy J Domingo, Paula A Trost, Peter T Erlandson, Philip A Klimkewicz, Prabhu P Raju, Ralph A Erickson, Ralph Jerndal, Raymond R Roy, PhD, Rebecca E Dombrowski, Rebecca L Mullikin, Regina T Brown, Robert C Coleman, Robert M Barbosa, Robert R Barbosa, Ronald G Crawford, Ronald R Ruff, Ross J Grigsby, Sana A Elassar, Sandra A Boyd, Sandra A Hughes, Sandra D Wilson, Sandra D Wilson Newby, Sanket N Patel, Sarah A Palmer, Sarah E Rhoades, Sarah M Napier, Schwierjohann Schwierjohann, Lindsey, Scott A Golladay, Scott B Laufenberg, Scott L Schenian, Sharon K Thoma, PharmD, Simone E Pitts, Srenda W Uratani, State Agency, Susan M Jackson, Susan M Matthias, Susan P Bruederle, Tamara J Umscheid, Tara M Carolfi, Tenzin Jangchup, Thomas A Peter, Thomas J Cosgrove, Tonnie L Carter, Tony T Yang, Tracey Asinjen Wiersma, Victoria L Palmer, Warren J Lopicka, William D Tingley, William E Keer, Yehualashet A Gessesse

James K Ireland's Documents

Publish Date Document Type Title
September, 2018 FDA 483 Response DIVERSIFIED MANUFACTURING CORP - Form 483R, 2018-10-16
June, 2016 EIR Sterling Wisconsin, LLC - EIR, 2016-06-24
September, 2018 FDA 483 DIVERSIFIED MANUFACTURING CORP - Form 483, 2018-09-28
November, 2016 EIR SAFC Inc - EIR, 2016-11-04
January, 2019 FDA 483 LTS Therapy Systems, LLC - Form 483, 2019-01-31
June, 2016 FDA 483 W & C dba The Apothecary - Form 483, 2016-06-17
August, 2018 FDA 483 Response Mayo Clinic Pharmacy - Form 483R, 2018-08-30
January, 2018 FDA 483 Beacon Promotions, Inc. - Form 483, 2018-01-12
October, 2019 FDA 483 Techni Med, Inc. dba The Compounder - Form 483, 2019-10-10
June, 2017 FDA 483 Bell International Laboratories, Inc - Form 483, 2017-06-22
April, 2018 FDA 483 Infuscience Inc - Form 483, 2018-04-25
March, 2017 FDA 483 LTS Therapy Systems, LLC - Form 483, 2017-03-29
December, 2018 FDA 483 EPIEN Medical, Inc. - Form 483, 2018-12-06
February, 2017 FDA 483 Celletech, Ltd - Form 483, 2017-02-03
September, 2019 EIR Phillips Medisize LLC - EIR, 2019-09-11
August, 2018 FDA 483 Mayo Clinic Pharmacy - Form 483, 2018-08-15
March, 2019 FDA 483 PROXIMAGEN LLC - Form 483, 2019-03-05
September, 2018 EIR Pharmacia & Upjohn Company LLC - EIR, 2018-09-21
July, 2017 FDA 483 Heartland I.V. Care - Form 483, 2017-07-14
September, 2018 FDA 483 Pharmacia & Upjohn Company LLC - Form 483, 2018-09-21
July, 2019 FDA 483 Radix Laboratories Incorporated - Form 483, 2019-07-25
March, 2017 FDA 483 Hillestad Pharmaceuticals USA - Form 483, 2017-03-03
September, 2018 EIR Pharmacia & Upjohn Company LLC - EIR, 2018-12-10

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.


Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more